MarketCap
Facebook
X
TelegramOsmotica Pharmaceuticals plc Finanzkreislauf | OSMT
Finanzkreislauf Jährlich Osmotica Pharmaceuticals plc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 87 | 130 | 95.2 | 98 | 105 | 95.3 | 112 | 76.5 | 54.2 | 58.4 | 53.4 |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 130 | 53.4 | 87.8 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AbbVie
ABBV
|
284 | $ 294.72 | 0.32 % | $ 521 B |  USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
33.4 | $ 4.63 | 21.05 % | $ 20 M |  Israel |
 |
Axon Enterprise
AXON
|
64.5 | $ 316.97 | 4.77 % | $ 24.7 B | USA |
 |
Bristol-Myers Squibb Company
BMY
|
58.6 | $ 62.89 | 0.18 % | $ 128 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-24.8 K | - | -15.15 % | $ 60.3 M |  Britain |
 |
Dynavax Technologies Corporation
DVAX
|
459 | - | - | $ 2.02 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
31.7 | $ 159.75 | 5.35 % | $ 20.9 B | USA |
 |
Amgen
AMGN
|
217 | $ 467.97 | 0.59 % | $ 252 B | USA |
 |
Orgenesis
ORGS
|
25.8 | - | -33.86 % | $ 61.2 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
66.2 | $ 248.31 | 1.17 % | $ 15.1 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
88.2 | $ 280.31 | -0.17 % | $ 675 B | USA |
 |
Kala Pharmaceuticals
KALA
|
729 | $ 0.17 | 0.64 % | $ 1.39 M | USA |
 |
Sage Therapeutics
SAGE
|
408 | - | - | $ 527 M | USA |
 |
Lineage Cell Therapeutics
LCTX
|
19.2 | $ 1.13 | 8.17 % | $ 260 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
252 | - | - | $ 121 M | USA |
 |
Eli Lilly and Company
LLY
|
291 | $ 1 437.4 | 0.36 % | $ 1.29 T | USA |
 |
Compugen Ltd.
CGEN
|
-82.7 | $ 2.09 | -0.24 % | $ 195 M | Israel |
 |
Crinetics Pharmaceuticals
CRNX
|
-4.27 K | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
GeoVax Labs
GOVX
|
48.4 | $ 2.13 | -20.4 % | $ 2.04 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
-284 | - | - | $ 521 M | USA |
 |
Seelos Therapeutics
SEEL
|
63.2 | - | -47.76 % | $ 6.27 M | USA |
 |
Celldex Therapeutics
CLDX
|
-307 | $ 30.18 | -1.53 % | $ 2 B | USA |
 |
Moderna
MRNA
|
-44.1 | $ 248.62 | -0.88 % | $ 96.7 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-90.5 | $ 3.96 | 1.41 % | $ 48.3 M | Israel |
 |
Nektar Therapeutics
NKTR
|
-29.3 | $ 38.41 | 1.67 % | $ 648 M | USA |
 |
CorMedix
CRMD
|
359 | $ 5.31 | -2.23 % | $ 383 K | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
-9.73 | $ 1.66 | -2.64 % | $ 1.12 B | Israel |
 |
Deciphera Pharmaceuticals
DCPH
|
-101 | - | - | $ 2.18 B | USA |
 |
Idera Pharmaceuticals
IDRA
|
158 | - | -23.04 % | $ 26.6 M | USA |
 |
Verona Pharma plc
VRNA
|
136 | - | - | $ 69.7 B | Britain |
 |
Oramed Pharmaceuticals
ORMP
|
-113 | $ 4.1 | 3.27 % | $ 170 M | Israel |